Crackdown a bitter drug to herald changes
By Cecily Liu in London, Zhang Yuwei in New York and Wang Hongyi in Shanghai | China Daily | Updated: 2013-07-26 08:32
Pharmaceutical companies keen to improve transparency, analysts say
China's crackdown on medical bribery will prompt foreign drugmakers to change their practices in the country, analysts said.
"We are already seeing these pharmaceutical companies' willingness to improve transparency and adjust their practices, and I believe it will happen," said Keith Bowman, an equity analyst at Hargreaves Lansdown Stockbrokers in London.
Photo
